Coles, Alasdair J <br/><br/>
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.  [electronic resource] 

 -  Journal of neurology  Jan 2006 
 - 98-108 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-5354 
<br/><br/><label>Standard No.: </label>10.1007/s00415-005-0934-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Autoimmunity--drug effects<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Disability Evaluation<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infant<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Multiple Sclerosis--therapy<br/>Retrospective Studies<br/>Secondary Prevention<br/>Time Factors